스마트 흡입기 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2033년)

Smart Inhalers Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

US $ 4,995 ￦ 7,088,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295 ￦ 10,352,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495 ￦ 12,055,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

한글목차

Persistence Market Research는 이번에 세계의 스마트 흡입기 시장에 관한 광범위한 리포트를 발행했습니다. 촉진요인·동향·기회·과제 등의 주요 시장 역학을 종합적으로 분석하고, 시장 구조에 관한 심층 인사이트를 제공하고 있습니다.

주요 인사이트

• 스마트 흡입기 시장 규모(2024년) : 9,790만 달러
• 예측 시장 금액(2033년) : 2억 3,570만 달러
• 세계 시장 성장률(CAGR 2024-2033년) : 10.3%

스마트 흡입기 시장 - 조사 범위 :

스마트 흡입기 시장에는 천식, 만성폐쇄성폐질환(COPD) 등 호흡기 질환을 앓고 있는 환자들을 돕기 위해 설계된 다양한 센서 및 연결 기능을 통합한 흡입기 장비가 포함됩니다. 이러한 스마트 기기는 환자의 복약 순응도를 높이고, 실시간 피드백을 제공하며, 의료진의 원격 모니터링을 용이하게 하는 데 있으며, 매우 중요합니다. 이 시장은 병원, 재택치료 환경, 전문 클리닉 등 다양한 부문에 서비스를 제공합니다. 호흡기 질환의 유병률 증가, 디지털 의료 기술의 발전, 다양한 의료 환경에서 원격의료의 적용 확대가 성장의 원동력이 되고 있습니다.

시장 성장의 촉진요인:

세계 스마트 흡입기 시장은 몇 가지 중요한 요인에 의해 주도되고 있습니다. 천식 및 COPD와 같은 호흡기 질환의 전 세계 유병률 증가는 이러한 환자들에게 일관되고 효과적인 약물 관리가 필요하므로 시장 성장의 중요한 요인으로 작용하고 있습니다. 센서, 모바일 앱과 흡입기 통합 등 디지털 헬스 및 커넥티드 디바이스의 기술 발전은 복약 순응도와 환자 결과를 개선해 시장 확대를 더욱 촉진하고 있습니다. 또한 복약 순응도의 중요성에 대한 인식이 높아지고 디지털 헬스 솔루션의 가용성이 증가함에 따라 수요를 촉진하고 있습니다. 혁신적인 스마트 흡입기 및 플랫폼의 도입과 함께 연구개발 활동의 강화는 다양한 의료 요구 사항을 가진 환자에게 보다 적합한 솔루션을 제공함으로써 시장 성장에 기여하고 있습니다.

시장 성장 억제요인 :

유망한 성장 전망에도 불구하고 스마트 흡입기 시장은 고급 스마트 흡입기 장비의 높은 비용과 연결된 건강 장비와 관련된 잠재적인 데이터 프라이버시 문제와 관련된 문제에 직면 해 있습니다. 일부 지역에서는 상환 정책이 없기 때문에 환자들이 이러한 첨단 기기를 구입하기 어려워 시장 성장을 저해할 수 있습니다. 또한 자원이 부족한 환경에서 스마트 흡입기의 접근성에 대한 우려는 시장 확대에 대한 도전이 되고 있습니다. 이러한 문제를 해결하기 위해서는 스마트 흡입기 장비의 경제성, 안전성 및 접근성을 개선하기 위한 연구개발에 대한 지속적인 투자가 필요합니다.

시장 기회 :

"이 시장은 환자 모니터링 및 결과 개선을 위한 디지털 헬스 플랫폼과 원격의료의 채택 증가로 큰 기회를 맞이하고 있으며, 블루투스 지원 흡입기 및 AI 기반 분석과 같은 첨단 센서 및 연결 기능의 개발은 보다 개인화된 데이터베이스 헬스케어 솔루션에 대한 수요 증가에 부응하고 있습니다. 개인화된 데이터베이스 헬스케어 솔루션에 대한 수요 증가에 대응하고 있습니다. 신흥 시장에서의 헬스케어 인프라 확대는 시장 성장을 위한 새로운 채널을 제공하고, 기업은 보다 광범위한 환자 집단에 도달하고 최첨단 스마트 흡입기 기술에 대한 접근성을 제공할 수 있습니다. 전략적 파트너십, 의료 전문가를 위한 교육 프로그램에 대한 투자, 환자 중심의 접근 방식을 채택하는 것은 새로운 기회를 활용하고 시장 리더십을 유지하는 데 필수적입니다.

이 보고서에서 다룬 주요 질문

• 세계 스마트 흡입기 시장의 성장을 가속하는 주요 요인은 무엇인가?
• 어떤 유형과 기술이 다양한 의료 환경에서 스마트 흡입기의 채택을 주도하고 있는가?
• 기술 발전은 스마트 흡입기 시장 경쟁 구도에 어떤 영향을 미쳤는가?
• 스마트 흡입기 시장의 주요 기업은 어디에 있으며, 경쟁을 유지하기 위해 어떤 전략을 채택하고 있는가?
• 세계 스마트 흡입기 시장의 새로운 동향과 전망은?

목차

제1장 개요

제2장 시장 개요

• 시장 범위 / 분류
• 시장의 정의 / 범위 / 제한
• 포함 사항·제외 사항

제3장 주요 시장 동향

• 시장에 영향을 미치는 주요 동향
• 혁신 / 개발 동향

제4장 주요 성공 요인

• 기술의 진보 규제 시나리오
• 주요 프로모션 전략 : 제조업체별
• 질병 역학 - COPD와 천식
• 신제품의 승인
• PESTEL 분석
• Porter의 산업 분석
• 밸류체인 분석

제5장 시장 배경

• 거시경제 요인
• 예측 요인 - 관련성과 영향
• 시장 역학

제6장 COVID-19 위기 분석

• 2022년 시장 시나리오
• COVID-19와 영향 분석
  • 제품별
  • 질환 적응증별
  • 유통 채널별
  • 지역별

제7장 세계의 스마트 흡입기 시장 수요(수량) 분석

• 과거 시장(수량) 분석, 2019-2023년
• 현재 및 향후 시장(수량) 예측, 2024-2033년
  • 전년대비 성장 동향 분석

제8장 세계의 스마트 흡입기 시장 - 가격 분석

• 지역별 가격 분석 : 제품별
• 가격 내역
  • 제조업체 레벨의 가격 설정
  • 유통업체 레벨의 가격 설정
• 세계 평균 가격 분석 벤치마크
• 가격결정 전제조건

제9장 세계의 스마트 흡입기 시장 수요(금액 또는 규모, 백만 달러) 분석

• 과거 시장 금액(백만 달러) 분석, 2019-2023년
• 현재 및 향후 시장 금액(백만 달러) 예측, 2024-2033년
  • 전년대비 성장 동향 분석
  • 절대액 기회 분석

제10장 세계의 스마트 흡입기 시장 분석, 제품별

• 서론 / 주요 조사 결과
• 과거 시장 규모(백만 달러)와 수량(단위) 분석, 제품별, 2019-2023년
• 현재 및 향후 시장 규모(백만 달러)와 수량(단위) 분석과 예측, 제품별, 2024-2033년
  • 드라이 파우더 흡입기(DPI) 기반 스마트 흡입기
  • 정량 분무식 흡입기(MDI) 기반 스마트 흡입기
• 시장의 매력 분석 : 제품별

제11장 세계의 스마트 흡입기 시장 분석, 질환 적응증별

• 서론 / 주요 조사 결과
• 과거 시장 규모(백만 달러) 분석 기술, 2019-2023년
• 현재 및 향후 시장 규모(백만 달러) 분석과 예측, 질환 적응증별, 2024-2033년
  • 천식
  • 만성 폐쇄성 폐질환
• 시장의 매력 분석 : 질환 적응증별

제12장 세계의 스마트 흡입기 시장 분석, 유통 채널별

• 서론 / 주요 조사 결과
• 과거 시장 규모(백만 달러) 분석 용도, 2019-2023년
• 현재 및 향후 시장 규모(백만 달러) 분석과 예측, 유통 채널별, 2024-2033년
  • 병원 약국
  • 소매 약국
  • 온라인 약국
• 시장의 매력 분석 : 유통 채널별

제13장 세계의 스마트 흡입기 시장 분석, 지역별

• 서론
• 과거 시장 규모(백만 달러)와 수량(단위) 분석, 지역별, 2019-2023년
• 현재 및 향후 시장 규모(백만 달러)와 수량(단위) 분석과 예측, 지역별, 2024-2033년
  • 북미
  • 라틴아메리카
  • 유럽
  • 남아시아
  • 동아시아
  • 오세아니아
  • 중동 및 아프리카
• 시장의 매력 분석 : 지역별

제14장 북미의 스마트 흡입기 시장 분석

제15장 라틴아메리카의 스마트 흡입기 시장 분석

제16장 유럽의 스마트 흡입기 시장 분석

제17장 남아시아의 스마트 흡입기 시장 분석

제18장 동아시아의 스마트 흡입기 시장 분석

제19장 오세아니아의 스마트 흡입기 시장 분석

제20장 중동 및 아프리카(MEA)의 스마트 흡입기 시장 분석

제21장 시장 구조 분석

• 시장 분석 : 기업 계층별
• 주요 기업의 시장 점유율 분석
• 시장 입지 분석

제22장 경쟁 분석

• 경쟁 대시보드
• 경쟁 벤치마킹
• 경쟁 상세 정보
  • OPKO Health, Inc
  • AstraZeneca plc
  • GlaxoSmithKline Plc.
  • Propeller Health
  • Aptar Pharma
  • Adherium Limited
  • Novartis AG
  • Boehringer Ingelheim
  • Teva Pharmaceutical Industries Ltd
  • H&T Presspart Manufacturing Ltd.
  • Sensirion AG
  • Cohero Health, Inc.
  • RYAH Medtech Inc.

제23장 사용되는 전제 조건과 두자어

제24장 조사 방법

KSA

영문 목차

영문목차

Persistence Market Research has recently published an extensive report on the global Smart Inhalers Market. This report offers a comprehensive analysis of the key market dynamics, including drivers, trends, opportunities, and challenges, providing deep insights into the market structure.

Key Insights:

• Smart Inhalers Market Size (2024E): US$97.9 Mn
• Projected Market Value (2033F): US$235.7 Mn
• Global Market Growth Rate (CAGR 2024 to 2033): 10.3%

Smart Inhalers Market - Report Scope:

The Smart Inhalers Market encompasses a variety of inhaler devices integrated with sensors and connectivity features designed to help patients with respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). These smart devices are pivotal in improving patient adherence to medication, providing real-time feedback, and facilitating remote monitoring by healthcare providers. The market serves diverse segments, including hospitals, home care settings, and specialty clinics. Growth is driven by the rising prevalence of respiratory diseases, advancements in digital health technologies, and the expanding application of telemedicine across various healthcare settings.

Market Growth Drivers:

Several key factors are driving the global Smart Inhalers Market. The increasing incidence of respiratory conditions such as asthma and COPD globally is a significant factor in the market's growth, as these patients require consistent and effective medication management. Technological advancements in digital health and connected devices, such as the integration of sensors and mobile apps with inhalers, have improved medication adherence and patient outcomes, further fueling market expansion. Additionally, the growing awareness of the importance of medication adherence and the increasing availability of digital health solutions drive demand. Enhanced research and development activities, along with the introduction of innovative smart inhalers and platforms, contribute to market growth by offering more tailored solutions for patients with varying medical needs.

Market Restraints:

Despite promising growth prospects, the Smart Inhalers Market faces challenges related to the high costs of advanced smart inhaler devices and the potential data privacy concerns associated with connected health devices. Market growth can be hindered by the lack of reimbursement policies in some regions, making it difficult for patients to afford these advanced devices. Additionally, concerns about the accessibility of smart inhalers in low-resource settings pose challenges for market expansion. Addressing these issues requires ongoing investment in research and development to improve the affordability, security, and accessibility of smart inhaler devices.

Market Opportunities:

The market presents significant opportunities driven by the increasing adoption of digital health platforms and telemedicine, which offer improved patient monitoring and outcomes. The development of advanced sensors and connectivity features, such as Bluetooth-enabled inhalers and AI-powered analytics, caters to the growing need for more personalized and data-driven healthcare solutions. The expansion of healthcare infrastructure in emerging markets provides new channels for market growth, allowing companies to reach a broader patient population and offer access to cutting-edge smart inhaler technologies. Strategic partnerships, investments in training programs for healthcare professionals, and the introduction of patient-centered approaches are essential for capitalizing on emerging opportunities and maintaining market leadership.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the Smart Inhalers Market globally?
• Which types and technologies of smart inhalers are leading the adoption in various healthcare settings?
• How are technological advancements influencing the competitive landscape of the Smart Inhalers Market?
• Who are the key players in the Smart Inhalers Market, and what strategies are they employing to stay competitive?
• What are the emerging trends and future prospects in the global Smart Inhalers Market?

Competitive Intelligence and Business Strategy:

Leading players in the global Smart Inhalers Market, including Adherium Limited, Teva Pharmaceuticals, and Propeller Health, focus on innovation, product differentiation, and strategic collaborations to gain a competitive edge. These companies invest in R&D to develop advanced smart inhaler solutions and explore new digital health technologies. Collaborations with healthcare providers, research institutions, and technology developers facilitate market access and promote new product adoption. Emphasis on patient education, high-quality products, and comprehensive training programs fosters market growth and enhances brand loyalty in the evolving Smart Inhalers Market landscape.

Key Companies Profiled:

• OPKO Health, Inc
• AstraZeneca plc
• GlaxoSmithKline Plc.
• Propeller Health
• Aptar Pharma
• Adherium Limited
• Novartis AG
• Boehringer Ingelheim
• Teva Pharmaceutical Industries Ltd
• H&T Presspart Manufacturing Ltd.
• Sensirion AG
• Cohero Health, Inc.
• RYAH Medtech Inc.

Smart Inhalers Market Industry Segmentation

By Product:

• Dry Powder Inhaler (DPI)- based Smart Inhalers
• Metered Dose Inhaler (MDI)- based Smart Inhalers

By Disease Indication:

• Asthma
• COPD

By Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand Side Trends
• 1.3. Supply Side Trends
• 1.4. Technology Roadmap
• 1.5. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations
• 2.3. Inclusion and Exclusions

3. Key Market Trends

• 3.1. Key Trends Impacting the Market
• 3.2. Innovation / Development Trends

4. Key Success Factors

• 4.1. Technological Advancements Regulatory Scenario
• 4.2. Key Promotional Strategies, By Manufacturers
• 4.3. Disease Epidemiology - COPD and Asthma
• 4.4. New Product Approvals
• 4.5. PESTEL Analysis
• 4.6. Porter's Analysis
• 4.7. Value Chain Analysis

5. Market Background

• 5.1. Macro-Economic Factors
  • 5.1.1. Global GDP Growth Outlook
  • 5.1.2. Global Healthcare Industry Outlook
  • 5.1.3. Respiratory Inhalers Market Analysis
• 5.2. Forecast Factors - Relevance & Impact
  • 5.2.1. Top Companies Historical Growth
  • 5.2.2. Lack of Awareness Regarding Symptoms of Asthma & COPD
  • 5.2.3. New Product Launches
  • 5.2.4. Growing Geriatric Population
  • 5.2.5. Increasing Prevalence of Asthma
  • 5.2.6. Product Adoption Rate
  • 5.2.7. Increased Funding and Support from the Government
• 5.3. Market Dynamics
  • 5.3.1. Drivers
  • 5.3.2. Restraints
  • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

• 6.1. 2022 Market Scenario
• 6.2. COVID-19 and Impact Analysis
  • 6.2.1. By Product
  • 6.2.2. By Disease Indication
  • 6.2.3. By Distribution Channel
  • 6.2.4. By Region

7. Global Smart Inhalers Market Demand (in Volume) Analysis 2019-2023 and Forecast, 2024-2033

• 7.1. Historical Market (Volume) Analysis, 2019-2023
• 7.2. Current and Future Market (Volume) Projections, 2024-2033
  • 7.2.1. Y-o-Y Growth Trend Analysis

8. Global Smart Inhalers Market- Pricing Analysis

• 8.1. Regional Pricing Analysis, By Product
• 8.2. Pricing Break-up
  • 8.2.1. Manufacturer-Level Pricing
  • 8.2.2. Distributor Level Pricing
• 8.3. Global Average Pricing Analysis Benchmark
• 8.4. Pricing Assumptions

9. Global Smart Inhalers Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033

• 9.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
• 9.2. Current and Future Market Value (US$ Mn) Projections, 2024-2033
  • 9.2.1. Y-o-Y Growth Trend Analysis
  • 9.2.2. Absolute $ Opportunity Analysis

10. Global Smart Inhalers Market Analysis 2019-2023 and Forecast 2024-2033, By Product

• 10.1. Introduction / Key Findings
• 10.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Product, 2019-2023
• 10.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2024-2033
  • 10.3.1. Dry Powder Inhaler (DPI)- based Smart Inhalers
  • 10.3.2. Metered Dose Inhaler (MDI)- based Smart Inhalers
• 10.4. Market Attractiveness Analysis, By Product

11. Global Smart Inhalers Market Analysis 2019-2023 and Forecast 2024-2033, By Disease Indication

• 11.1. Introduction / Key Findings
• 11.2. Historical Market Size (US$ Mn) Analysis Technology, 2019-2023
• 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, By Disease Indication, 2024-2033
  • 11.3.1. Asthma
  • 11.3.2. COPD
• 11.4. Market Attractiveness Analysis, By Disease Indication

12. Global Smart Inhalers Market Analysis 2019-2023 and Forecast 2024-2033, By Distribution Channel

• 12.1. Introduction / Key Findings
• 12.2. Historical Market Size (US$ Mn) Analysis Application, 2019-2023
• 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2024-2033
  • 12.3.1. Hospital Pharmacies
  • 12.3.2. Retail Pharmacies
  • 12.3.3. Online Pharmacies
• 12.4. Market Attractiveness Analysis, By Distribution Channel

13. Global Smart Inhalers Market Analysis 2019-2023 and Forecast 2024-2033, By Region

• 13.1. Introduction
• 13.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Region, 2019-2023
• 13.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Region, 2024-2033
  • 13.3.1. North America
  • 13.3.2. Latin America
  • 13.3.3. Europe
  • 13.3.4. South Asia
  • 13.3.5. East Asia
  • 13.3.6. Oceania
  • 13.3.7. Middle East and Africa
• 13.4. Market Attractiveness Analysis, By Region

14. North America Smart Inhalers Market Analysis 2019-2023 and Forecast 2024-2033

• 14.1. Introduction
• 14.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2019-2023
• 14.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2024-2033
  • 14.3.1. By Country
    • 14.3.1.1. U.S.
    • 14.3.1.2. Canada
  • 14.3.2. By Product
  • 14.3.3. By Disease Indication
  • 14.3.4. By Distribution Channel
• 14.4. Market Attractiveness Analysis
  • 14.4.1. By Country
  • 14.4.2. By Product
  • 14.4.3. By Disease Indication
  • 14.4.4. By Distribution Channel
• 14.5. Key Market Participants - Intensity Mapping
• 14.6. Drivers and Restraints - Impact Analysis
• 14.7. Key Market Trends
• 14.8. Country-Level Analysis & Forecast
  • 14.8.1. U.S. Smart Inhalers Market
    • 14.8.1.1. Introduction
    • 14.8.1.2. Market Analysis and Forecast, By Market Taxonomy
      • 14.8.1.2.1. By Product
      • 14.8.1.2.2. By Disease Indication
      • 14.8.1.2.3. By Distribution Channel
  • 14.8.2. Canada Smart Inhalers Market
    • 14.8.2.1. Introduction
    • 14.8.2.2. Market Analysis and Forecast, By Market Taxonomy
      • 14.8.2.2.1. By Product
      • 14.8.2.2.2. By Disease Indication
      • 14.8.2.2.3. By Distribution Channel

15. Latin America Smart Inhalers Market Analysis 2019-2023 and Forecast 2024-2033

• 15.1. Introduction
• 15.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2019-2023
• 15.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2024-2033
  • 15.3.1. By Country
    • 15.3.1.1. Brazil
    • 15.3.1.2. Argentina
    • 15.3.1.3. Mexico
    • 15.3.1.4. Rest of Latin America
  • 15.3.2. By Product
  • 15.3.3. By Disease Indication
  • 15.3.4. By Distribution Channel
• 15.4. Market Attractiveness Analysis
  • 15.4.1. By Country
  • 15.4.2. By Product
  • 15.4.3. By Disease Indication
  • 15.4.4. By Distribution Channel
• 15.5. Key Market Participants - Intensity Mapping
• 15.6. Drivers and Restraints - Impact Analysis
• 15.7. Key Market Trends
• 15.8. Country-Level Analysis & Forecast
  • 15.8.1. Brazil Smart Inhalers Market
    • 15.8.1.1. Introduction
    • 15.8.1.2. Market Analysis and Forecast, By Market Taxonomy
      • 15.8.1.2.1. By Product
      • 15.8.1.2.2. By Disease Indication
      • 15.8.1.2.3. By Distribution Channel
  • 15.8.2. Argentina Surgical Imaging Market
    • 15.8.2.1. Introduction
    • 15.8.2.2. Market Analysis and Forecast, By Market Taxonomy
      • 15.8.2.2.1. By Product
      • 15.8.2.2.2. By Disease Indication
      • 15.8.2.2.3. By Distribution Channel
  • 15.8.3. Mexico Smart Inhalers Market
    • 15.8.3.1. Introduction
    • 15.8.3.2. Market Analysis and Forecast, By Market Taxonomy
      • 15.8.3.2.1. By Product
      • 15.8.3.2.2. By Disease Indication
      • 15.8.3.2.3. By Distribution Channel

16. Europe Smart Inhalers Market Analysis 2019-2023 and Forecast 2024-2033

• 16.1. Introduction
• 16.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2019-2023
• 16.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2024-2033
  • 16.3.1. By Country
    • 16.3.1.1. Germany
    • 16.3.1.2. Italy
    • 16.3.1.3. France
    • 16.3.1.4. U.K.
    • 16.3.1.5. Spain
    • 16.3.1.6. BENELUX
    • 16.3.1.7. Russia
    • 16.3.1.8. Rest of Europe
  • 16.3.2. By Product
  • 16.3.3. By Disease Indication
  • 16.3.4. By Distribution Channel
• 16.4. Market Attractiveness Analysis
  • 16.4.1. By Country
  • 16.4.2. By Product
  • 16.4.3. By Disease Indication
  • 16.4.4. By Distribution Channel
• 16.5. Key Market Participants - Intensity Mapping
• 16.6. Drivers and Restraints - Impact Analysis
• 16.7. Key Market Trends
• 16.8. Country-Level Analysis & Forecast
  • 16.8.1. Germany Smart Inhalers Market
    • 16.8.1.1. Introduction
    • 16.8.1.2. Market Analysis and Forecast, By Market Taxonomy
      • 16.8.1.2.1. By Product
      • 16.8.1.2.2. By Disease Indication
      • 16.8.1.2.3. By Distribution Channel
  • 16.8.2. France Smart Inhalers Market
    • 16.8.2.1. Introduction
    • 16.8.2.2. Market Analysis and Forecast, By Market Taxonomy
      • 16.8.2.2.1. By Product
      • 16.8.2.2.2. By Disease Indication
      • 16.8.2.2.3. By Distribution Channel
  • 16.8.3. Italy Smart Inhalers Market
    • 16.8.3.1. Introduction
    • 16.8.3.2. Market Analysis and Forecast, By Market Taxonomy
      • 16.8.3.2.1. By Product
      • 16.8.3.2.2. By Disease Indication
      • 16.8.3.2.3. By Distribution Channel
  • 16.8.4. Spain Smart Inhalers Market
    • 16.8.4.1. Introduction
    • 16.8.4.2. Market Analysis and Forecast, By Market Taxonomy
      • 16.8.4.2.1. By Product
      • 16.8.4.2.2. By Disease Indication
      • 16.8.4.2.3. By Distribution Channel
  • 16.8.5. U.K. Smart Inhalers Market
    • 16.8.5.1. Introduction
    • 16.8.5.2. Market Analysis and Forecast, By Market Taxonomy
      • 16.8.5.2.1. By Product
      • 16.8.5.2.2. By Disease Indication
      • 16.8.5.2.3. By Distribution Channel
  • 16.8.6. BENULUX Smart Inhalers Market
    • 16.8.6.1. Introduction
    • 16.8.6.2. Market Analysis and Forecast, By Market Taxonomy
      • 16.8.6.2.1. By Product
      • 16.8.6.2.2. By Disease Indication
      • 16.8.6.2.3. By Distribution Channel
  • 16.8.7. Russia Smart Inhalers Market
    • 16.8.7.1. Introduction
    • 16.8.7.2. Market Analysis and Forecast, By Market Taxonomy
      • 16.8.7.2.1. By Product
      • 16.8.7.2.2. By Disease Indication
      • 16.8.7.2.3. By Distribution Channel

17. South Asia Smart Inhalers Market Analysis 2019-2023 and Forecast 2024-2033

• 17.1. Introduction
• 17.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2019-2023
• 17.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2024-2033
  • 17.3.1. By Country
    • 17.3.1.1. India
    • 17.3.1.2. Thailand
    • 17.3.1.3. Indonesia
    • 17.3.1.4. Malaysia
    • 17.3.1.5. Rest of South Asia
  • 17.3.2. By Product
  • 17.3.3. By Disease Indication
  • 17.3.4. By Distribution Channel
• 17.4. Market Attractiveness Analysis
  • 17.4.1. By Country
  • 17.4.2. By Product
  • 17.4.3. By Disease Indication
  • 17.4.4. By Distribution Channel
• 17.5. Key Market Participants - Intensity Mapping
• 17.6. Drivers and Restraints - Impact Analysis
• 17.7. Key Market Trends
• 17.8. Country-Level Analysis & Forecast
  • 17.8.1. India Smart Inhalers Market
    • 17.8.1.1. Introduction
    • 17.8.1.2. Market Analysis and Forecast, By Market Taxonomy
      • 17.8.1.2.1. By Product
      • 17.8.1.2.2. By Disease Indication
      • 17.8.1.2.3. By Distribution Channel
  • 17.8.2. Indonesia Smart Inhalers Market
    • 17.8.2.1. Introduction
    • 17.8.2.2. Market Analysis and Forecast, By Market Taxonomy
      • 17.8.2.2.1. By Product
      • 17.8.2.2.2. By Disease Indication
      • 17.8.2.2.3. By Distribution Channel
  • 17.8.3. Malaysia Smart Inhalers Market
    • 17.8.3.1. Introduction
    • 17.8.3.2. Market Analysis and Forecast, By Market Taxonomy
      • 17.8.3.2.1. By Product
      • 17.8.3.2.2. By Disease Indication
      • 17.8.3.2.3. By Distribution Channel
  • 17.8.4. Thailand Smart Inhalers Market
    • 17.8.4.1. Introduction
    • 17.8.4.2. Market Analysis and Forecast, By Market Taxonomy
      • 17.8.4.2.1. By Product
      • 17.8.4.2.2. By Disease Indication
      • 17.8.4.2.3. By Distribution Channel

18. East Asia Smart Inhalers Market Analysis 2019-2023 and Forecast 2024-2033

• 18.1. Introduction
• 18.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2019-2023
• 18.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2024-2033
  • 18.3.1. By Country
    • 18.3.1.1. China
    • 18.3.1.2. Japan
    • 18.3.1.3. South Korea
  • 18.3.2. By Product
  • 18.3.3. By Disease Indication
  • 18.3.4. By Distribution Channel
• 18.4. Market Attractiveness Analysis
  • 18.4.1. By Country
  • 18.4.2. By Product
  • 18.4.3. By Disease Indication
  • 18.4.4. By Distribution Channel
• 18.5. Key Market Participants - Intensity Mapping
• 18.6. Drivers and Restraints - Impact Analysis
• 18.7. Key Market Trends
• 18.8. Country-Level Analysis & Forecast
  • 18.8.1. China Smart Inhalers Market
    • 18.8.1.1. Introduction
    • 18.8.1.2. Market Analysis and Forecast, By Market Taxonomy
      • 18.8.1.2.1. By Product
      • 18.8.1.2.2. By Disease Indication
      • 18.8.1.2.3. By Distribution Channel
  • 18.8.2. Japan Smart Inhalers Market
    • 18.8.2.1. Introduction
    • 18.8.2.2. Market Analysis and Forecast, By Market Taxonomy
      • 18.8.2.2.1. By Product
      • 18.8.2.2.2. By Disease Indication
      • 18.8.2.2.3. By Distribution Channel
  • 18.8.3. South Korea Smart Inhalers Market
    • 18.8.3.1. Introduction
    • 18.8.3.2. Market Analysis and Forecast, By Market Taxonomy
      • 18.8.3.2.1. By Product
      • 18.8.3.2.2. By Disease Indication
      • 18.8.3.2.3. By Distribution Channel

19. Oceania Smart Inhalers Market Analysis 2019-2023 and Forecast 2024-2033

• 19.1. Introduction
• 19.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2019-2023
• 19.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2024-2033
  • 19.3.1. By Country
    • 19.3.1.1. Australia
    • 19.3.1.2. New Zealand
  • 19.3.2. By Product
  • 19.3.3. By Disease Indication
  • 19.3.4. By Distribution Channel
• 19.4. Market Attractiveness Analysis
  • 19.4.1. By Country
  • 19.4.2. By Product
  • 19.4.3. By Disease Indication
  • 19.4.4. By Distribution Channel
• 19.5. Key Market Participants - Intensity Mapping
• 19.6. Drivers and Restraints - Impact Analysis
• 19.7. Key Market Trends
• 19.8. Country-Level Analysis & Forecast
  • 19.8.1. Australia Smart Inhalers Market
    • 19.8.1.1. Introduction
    • 19.8.1.2. Market Analysis and Forecast, By Market Taxonomy
      • 19.8.1.2.1. By Product
      • 19.8.1.2.2. By Disease Indication
      • 19.8.1.2.3. By Distribution Channel
  • 19.8.2. New Zealand Smart Inhalers Market
    • 19.8.2.1. Introduction
    • 19.8.2.2. Market Analysis and Forecast, By Market Taxonomy
      • 19.8.2.2.1. By Product
      • 19.8.2.2.2. By Disease Indication
      • 19.8.2.2.3. By Distribution Channel

20. Middle East and Africa (MEA) Smart Inhalers Market Analysis 2019-2023 and Forecast 2024-2033

• 20.1. Introduction
• 20.2. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis, By Market Taxonomy, 2019-2023
• 20.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Market Taxonomy, 2024-2033
  • 20.3.1. By Country
    • 20.3.1.1. GCC Countries
    • 20.3.1.2. Turkey
    • 20.3.1.3. North Africa
    • 20.3.1.4. South Africa
    • 20.3.1.5. Rest of Middle East and Africa
  • 20.3.2. By Product
  • 20.3.3. By Disease Indication
  • 20.3.4. By Distribution Channel
• 20.4. Market Attractiveness Analysis
  • 20.4.1. By Country
  • 20.4.2. By Product
  • 20.4.3. By Disease Indication
  • 20.4.4. By Distribution Channel
• 20.5. Key Market Participants - Intensity Mapping
• 20.6. Drivers and Restraints - Impact Analysis
• 20.7. Key Market Trends
• 20.8. Country-Level Analysis & Forecast
  • 20.8.1. GCC Countries Smart Inhalers Market
    • 20.8.1.1. Introduction
    • 20.8.1.2. Market Analysis and Forecast, By Market Taxonomy
      • 20.8.1.2.1. By Product
      • 20.8.1.2.2. By Disease Indication
      • 20.8.1.2.3. By Distribution Channel
  • 20.8.2. Turkey Smart Inhalers Market
    • 20.8.2.1. Introduction
    • 20.8.2.2. Market Analysis and Forecast, By Market Taxonomy
      • 20.8.2.2.1. By Product
      • 20.8.2.2.2. By Disease Indication
      • 20.8.2.2.3. By Distribution Channel
  • 20.8.3. South Africa Smart Inhalers Market
    • 20.8.3.1. Introduction
    • 20.8.3.2. Market Analysis and Forecast, By Market Taxonomy
      • 20.8.3.2.1. By Product
      • 20.8.3.2.2. By Disease Indication
      • 20.8.3.2.3. By Distribution Channel
  • 20.8.4. North Africa Smart Inhalers Market
    • 20.8.4.1. Introduction
    • 20.8.4.2. Market Analysis and Forecast, By Market Taxonomy
      • 20.8.4.2.1. By Product
      • 20.8.4.2.2. By Disease Indication
      • 20.8.4.2.3. By Distribution Channel

21. Market Structure Analysis

• 21.1. Market Analysis, By Tier of Companies
• 21.2. Market Share Analysis of Top Players
• 21.3. Market Presence Analysis
  • 21.3.1. Regional footprint of Players
  • 21.3.2. Platform Type foot print by Players
  • 21.3.3. Channel Foot Print by Players

22. Competition Analysis

• 22.1. Competition Dashboard
• 22.2. Competition Benchmarking
• 22.3. Competition Deep Dive
  • 22.3.1. OPKO Health, Inc
    • 22.3.1.1. Market Analysis by Tier of Companies
    • 22.3.1.2. Market Share Analysis of Top Players
    • 22.3.1.3. Market Presence Analysis
    • 22.3.1.4. Competition Dashboard
    • 22.3.1.5. Competition Deep Dive
    • 22.3.1.6. Strategy Analysis
      • 22.3.1.6.1. Marketing Strategy
      • 22.3.1.6.2. Product Strategy
      • 22.3.1.6.3. Channel Strategy
  • 22.3.2. AstraZeneca plc
    • 22.3.2.1. Market Analysis by Tier of Companies
    • 22.3.2.2. Market Share Analysis of Top Players
    • 22.3.2.3. Market Presence Analysis
    • 22.3.2.4. Competition Dashboard
    • 22.3.2.5. Competition Deep Dive
    • 22.3.2.6. Strategy Analysis
      • 22.3.2.6.1. Marketing Strategy
      • 22.3.2.6.2. Product Strategy
      • 22.3.2.6.3. Channel Strategy
  • 22.3.3. GlaxoSmithKline Plc.
    • 22.3.3.1. Market Analysis by Tier of Companies
    • 22.3.3.2. Market Share Analysis of Top Players
    • 22.3.3.3. Market Presence Analysis
    • 22.3.3.4. Competition Dashboard
    • 22.3.3.5. Competition Deep Dive
    • 22.3.3.6. Strategy Analysis
      • 22.3.3.6.1. Marketing Strategy
      • 22.3.3.6.2. Product Strategy
      • 22.3.3.6.3. Channel Strategy
  • 22.3.4. Propeller Health
    • 22.3.4.1. Market Analysis by Tier of Companies
    • 22.3.4.2. Market Share Analysis of Top Players
    • 22.3.4.3. Market Presence Analysis
    • 22.3.4.4. Competition Dashboard
    • 22.3.4.5. Competition Deep Dive
    • 22.3.4.6. Strategy Analysis
      • 22.3.4.6.1. Marketing Strategy
      • 22.3.4.6.2. Product Strategy
      • 22.3.4.6.3. Channel Strategy
  • 22.3.5. Aptar Pharma
    • 22.3.5.1. Market Analysis by Tier of Companies
    • 22.3.5.2. Market Share Analysis of Top Players
    • 22.3.5.3. Market Presence Analysis
    • 22.3.5.4. Competition Dashboard
    • 22.3.5.5. Competition Deep Dive
    • 22.3.5.6. Strategy Analysis
      • 22.3.5.6.1. Marketing Strategy
      • 22.3.5.6.2. Product Strategy
      • 22.3.5.6.3. Channel Strategy
  • 22.3.6. Adherium Limited
    • 22.3.6.1. Market Analysis by Tier of Companies
    • 22.3.6.2. Market Share Analysis of Top Players
    • 22.3.6.3. Market Presence Analysis
    • 22.3.6.4. Competition Dashboard
    • 22.3.6.5. Competition Deep Dive
    • 22.3.6.6. Strategy Analysis
      • 22.3.6.6.1. Marketing Strategy
      • 22.3.6.6.2. Product Strategy
      • 22.3.6.6.3. Channel Strategy
  • 22.3.7. Novartis AG
    • 22.3.7.1. Market Analysis by Tier of Companies
    • 22.3.7.2. Market Share Analysis of Top Players
    • 22.3.7.3. Market Presence Analysis
    • 22.3.7.4. Competition Dashboard
    • 22.3.7.5. Competition Deep Dive
    • 22.3.7.6. Strategy Analysis
      • 22.3.7.6.1. Marketing Strategy
      • 22.3.7.6.2. Product Strategy
      • 22.3.7.6.3. Channel Strategy
  • 22.3.8. Boehringer Ingelheim
    • 22.3.8.1. Market Analysis by Tier of Companies
    • 22.3.8.2. Market Share Analysis of Top Players
    • 22.3.8.3. Market Presence Analysis
    • 22.3.8.4. Competition Dashboard
    • 22.3.8.5. Competition Deep Dive
    • 22.3.8.6. Strategy Analysis
      • 22.3.8.6.1. Marketing Strategy
      • 22.3.8.6.2. Product Strategy
      • 22.3.8.6.3. Channel Strategy
  • 22.3.9. Teva Pharmaceutical Industries Ltd
    • 22.3.9.1. Market Analysis by Tier of Companies
    • 22.3.9.2. Market Share Analysis of Top Players
    • 22.3.9.3. Market Presence Analysis
    • 22.3.9.4. Competition Dashboard
    • 22.3.9.5. Competition Deep Dive
    • 22.3.9.6. Strategy Analysis
      • 22.3.9.6.1. Marketing Strategy
      • 22.3.9.6.2. Product Strategy
      • 22.3.9.6.3. Channel Strategy
  • 22.3.10. H&T Presspart Manufacturing Ltd.
    • 22.3.10.1. Market Analysis by Tier of Companies
    • 22.3.10.2. Market Share Analysis of Top Players
    • 22.3.10.3. Market Presence Analysis
    • 22.3.10.4. Competition Dashboard
    • 22.3.10.5. Competition Deep Dive
    • 22.3.10.6. Strategy Analysis
      • 22.3.10.6.1. Marketing Strategy
      • 22.3.10.6.2. Product Strategy
      • 22.3.10.6.3. Channel Strategy
  • 22.3.11. Sensirion AG
    • 22.3.11.1. Market Analysis by Tier of Companies
    • 22.3.11.2. Market Share Analysis of Top Players
    • 22.3.11.3. Market Presence Analysis
    • 22.3.11.4. Competition Dashboard
    • 22.3.11.5. Competition Deep Dive
    • 22.3.11.6. Strategy Analysis
      • 22.3.11.6.1. Marketing Strategy
      • 22.3.11.6.2. Product Strategy
      • 22.3.11.6.3. Channel Strategy
  • 22.3.12. Cohero Health, Inc.
    • 22.3.12.1. Market Analysis by Tier of Companies
    • 22.3.12.2. Market Share Analysis of Top Players
    • 22.3.12.3. Market Presence Analysis
    • 22.3.12.4. Competition Dashboard
    • 22.3.12.5. Competition Deep Dive
    • 22.3.12.6. Strategy Analysis
      • 22.3.12.6.1. Marketing Strategy
      • 22.3.12.6.2. Product Strategy
      • 22.3.12.6.3. Channel Strategy
  • 22.3.13. RYAH Medtech Inc.
    • 22.3.13.1. Market Analysis by Tier of Companies
    • 22.3.13.2. Market Share Analysis of Top Players
    • 22.3.13.3. Market Presence Analysis
    • 22.3.13.4. Competition Dashboard
    • 22.3.13.5. Competition Deep Dive
    • 22.3.13.6. Strategy Analysis
      • 22.3.13.6.1. Marketing Strategy
      • 22.3.13.6.2. Product Strategy
      • 22.3.13.6.3. Channel Strategy

23. Assumptions and Acronyms Used

24. Research Methodology

관련자료